明智选择——何时用体外膜肺氧合（ECMO）修复破碎的心？
Choosing wisely - when to mend a broken heart with ECMO?
作者信息
Stephens R, Fan Eddy
出版信息
Crit Care. 2014 Feb 20;18(1):112. doi: 10.1186/cc13736.
Abstract
Refractory cardiac shock in the cardiac surgical intensive care unit confers significant morbidity and mortality. Extracorporeal membrane oxygenation (ECMO) has become a common intervention for refractory cardiogenic shock when other therapies have failed. However, it is difficult to predict who will benefit from this costly, resource-intensive, but potentially life-saving technology. Here, we discuss the utility of a novel biomarker, serum butylcholinesterase, in determining survival in patients supported with ECMO following cardiac surgery.
摘要
心脏外科重症监护病房中的难治性心源性休克会导致显著的发病率和死亡率。当其他治疗方法失败时，体外膜肺氧合（ECMO）已成为治疗难治性心源性休克的常用干预措施。然而，很难预测谁将从这种昂贵、资源密集但可能挽救生命的技术中获益。在此，我们讨论一种新型生物标志物——血清丁酰胆碱酯酶在确定心脏手术后接受ECMO支持的患者生存情况方面的效用。
相似文献
1
Choosing wisely - when to mend a broken heart with ECMO?
Crit Care. 2014 Feb 20;18(1):112. doi: 10.1186/cc13736.
2
Serum butyrylcholinesterase predicts survival after extracorporeal membrane oxygenation after cardiovascular surgery.
Crit Care. 2014 Jan 30;18(1):R24. doi: 10.1186/cc13711.
3
Extracorporeal membrane oxygenation for refractory cardiogenic shock after cardiac surgery: predictors of early mortality and outcome from 51 adult patients.
Eur J Cardiothorac Surg. 2010 Feb;37(2):328-33. doi: 10.1016/j.ejcts.2009.07.033. Epub 2009 Sep 12.
4
Clinical outcomes in patients after extracorporeal membrane oxygenation support for post-cardiotomy cardiogenic shock: a single-centre experience of 92 cases.
Interact Cardiovasc Thorac Surg. 2017 Sep 1;25(3):363-369. doi: 10.1093/icvts/ivx155.
5
Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: a retrospective study of the Extracorporeal Life Support Organizations' ECMO case registry.
Clin Toxicol (Phila). 2020 Jul;58(7):705-710. doi: 10.1080/15563650.2019.1676896. Epub 2019 Oct 16.
6
Venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock post-cardiac arrest.
Intensive Care Med. 2016 Dec;42(12):1999-2007. doi: 10.1007/s00134-016-4541-y. Epub 2016 Sep 28.
7
Usefulness of cardiac biomarkers to predict cardiac recovery in patients on extracorporeal membrane oxygenation support for refractory cardiogenic shock.
J Crit Care. 2012 Oct;27(5):524.e7-14. doi: 10.1016/j.jcrc.2011.12.009. Epub 2012 Mar 2.
8
Cardiac arrest does not affect survival in post-operative cardiovascular surgery patients undergoing extracorporeal membrane oxygenation.
Resuscitation. 2016 Jul;104:24-7. doi: 10.1016/j.resuscitation.2016.03.028. Epub 2016 Apr 21.
9
Overview of extracorporeal membrane oxygenation in cardiogenic shock.
Crit Care Nurs Clin North Am. 2014 Dec;26(4):581-8. doi: 10.1016/j.ccell.2014.08.002. Epub 2014 Sep 16.
10
The Effect of Simultaneous Renal Replacement Therapy on Extracorporeal Membrane Oxygenation Support for Postcardiotomy Patients with Cardiogenic Shock: A Pilot Randomized Controlled Trial.
J Cardiothorac Vasc Anesth. 2019 Nov;33(11):3063-3072. doi: 10.1053/j.jvca.2019.02.031. Epub 2019 Feb 21.
本文引用的文献
1
Serum butyrylcholinesterase predicts survival after extracorporeal membrane oxygenation after cardiovascular surgery.
Crit Care. 2014 Jan 30;18(1):R24. doi: 10.1186/cc13711.
2
The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome.
Intensive Care Med. 2013 Oct;39(10):1704-13. doi: 10.1007/s00134-013-3037-2. Epub 2013 Aug 2.
3
Long-term mortality in patients with chronic obstructive pulmonary disease following extracorporeal membrane oxygenation for cardiac assist after cardiovascular surgery.
Intensive Care Med. 2013 Aug;39(8):1444-51. doi: 10.1007/s00134-013-2931-y. Epub 2013 Apr 24.
4
Usefulness of cardiac biomarkers to predict cardiac recovery in patients on extracorporeal membrane oxygenation support for refractory cardiogenic shock.
J Crit Care. 2012 Oct;27(5):524.e7-14. doi: 10.1016/j.jcrc.2011.12.009. Epub 2012 Mar 2.
5
Butyrylcholinesterase activity predicts long-term survival in patients with coronary artery disease.
Clin Chem. 2012 Jun;58(6):1055-8. doi: 10.1373/clinchem.2011.175984. Epub 2012 Jan 31.
6
Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock.
Intensive Care Med. 2011 Nov;37(11):1738-45. doi: 10.1007/s00134-011-2358-2. Epub 2011 Oct 1.
7
Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality.
Mol Med. 2010 Jul-Aug;16(7-8):278-86. doi: 10.2119/molmed.2010.00015. Epub 2010 Apr 14.
8
Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock.
J Thorac Cardiovasc Surg. 2010 Feb;139(2):302-11, 311.e1. doi: 10.1016/j.jtcvs.2009.10.043.
9
Butyrylcholinesterase activity and mortality risk in hemodialysis patients: comparison to hsCRP and albumin.
Clin Biochem. 2009 Jan;42(1-2):22-6. doi: 10.1016/j.clinbiochem.2008.10.010. Epub 2008 Nov 5.
10
Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and women in Jerusalem.
Clin Chem. 2006 May;52(5):845-52. doi: 10.1373/clinchem.2005.059857. Epub 2006 Mar 9.
Zotero 插件